275 related articles for article (PubMed ID: 34768996)
1. A Review of Calcineurin Biophysics with Implications for Cardiac Physiology.
Williams RB; Johnson CN
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768996
[TBL] [Abstract][Full Text] [Related]
2. Calcineurin-dependent ion channel regulation in heart.
Wang Y; Tandan S; Hill JA
Trends Cardiovasc Med; 2014 Jan; 24(1):14-22. PubMed ID: 23809405
[TBL] [Abstract][Full Text] [Related]
3. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs.
Molkentin JD
Cardiovasc Res; 2004 Aug; 63(3):467-75. PubMed ID: 15276472
[TBL] [Abstract][Full Text] [Related]
4. The novel cardiac z-disc protein CEFIP regulates cardiomyocyte hypertrophy by modulating calcineurin signaling.
Dierck F; Kuhn C; Rohr C; Hille S; Braune J; Sossalla S; Molt S; van der Ven PFM; Fürst DO; Frey N
J Biol Chem; 2017 Sep; 292(37):15180-15191. PubMed ID: 28717008
[TBL] [Abstract][Full Text] [Related]
5. Cardiomyocyte calcineurin signaling in subcellular domains: from the sarcolemma to the nucleus and beyond.
Heineke J; Ritter O
J Mol Cell Cardiol; 2012 Jan; 52(1):62-73. PubMed ID: 22064325
[TBL] [Abstract][Full Text] [Related]
6. Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes.
Fiedler B; Wollert KC
Cardiovasc Res; 2004 Aug; 63(3):450-7. PubMed ID: 15276470
[TBL] [Abstract][Full Text] [Related]
7. Carabin protects against cardiac hypertrophy by blocking calcineurin, Ras, and Ca2+/calmodulin-dependent protein kinase II signaling.
Bisserier M; Berthouze-Duquesnes M; Breckler M; Tortosa F; Fazal L; de Régibus A; Laurent AC; Varin A; Lucas A; Branchereau M; Marck P; Schickel JN; Deloménie C; Cazorla O; Soulas-Sprauel P; Crozatier B; Morel E; Heymes C; Lezoualc'h F
Circulation; 2015 Jan; 131(4):390-400; discussion 400. PubMed ID: 25369805
[TBL] [Abstract][Full Text] [Related]
8. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy.
Wilkins BJ; Molkentin JD
Biochem Biophys Res Commun; 2004 Oct; 322(4):1178-91. PubMed ID: 15336966
[TBL] [Abstract][Full Text] [Related]
9. Cardiac anti-remodelling effect of aerobic training is associated with a reduction in the calcineurin/NFAT signalling pathway in heart failure mice.
Oliveira RS; Ferreira JC; Gomes ER; Paixão NA; Rolim NP; Medeiros A; Guatimosim S; Brum PC
J Physiol; 2009 Aug; 587(Pt 15):3899-910. PubMed ID: 19505981
[TBL] [Abstract][Full Text] [Related]
10. Estrogen inhibits cardiomyocyte hypertrophy in vitro. Antagonism of calcineurin-related hypertrophy through induction of MCIP1.
Pedram A; Razandi M; Aitkenhead M; Levin ER
J Biol Chem; 2005 Jul; 280(28):26339-48. PubMed ID: 15899894
[TBL] [Abstract][Full Text] [Related]
11. Cardiac-Specific EPI64C Blunts Pressure Overload-Induced Cardiac Hypertrophy.
Zhu X; Fang J; Gong J; Guo JH; Zhao GN; Ji YX; Liu HY; Wei X; Li H
Hypertension; 2016 May; 67(5):866-77. PubMed ID: 27021007
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of calmodulin induces cardiac hypertrophy by a calcineurin-dependent pathway.
Obata K; Nagata K; Iwase M; Odashima M; Nagasaka T; Izawa H; Murohara T; Yamada Y; Yokota M
Biochem Biophys Res Commun; 2005 Dec; 338(2):1299-305. PubMed ID: 16256941
[TBL] [Abstract][Full Text] [Related]
13. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
[TBL] [Abstract][Full Text] [Related]
14. Chapter 2. Calcineurin signaling and the slow oxidative skeletal muscle fiber type.
Mallinson J; Meissner J; Chang KC
Int Rev Cell Mol Biol; 2009; 277():67-101. PubMed ID: 19766967
[TBL] [Abstract][Full Text] [Related]
15. Calcineurin Aβ-Specific Anchoring Confers Isoform-Specific Compartmentation and Function in Pathological Cardiac Myocyte Hypertrophy.
Li X; Li J; Martinez EC; Froese A; Passariello CL; Henshaw K; Rusconi F; Li Y; Yu Q; Thakur H; Nikolaev VO; Kapiloff MS
Circulation; 2020 Sep; 142(10):948-962. PubMed ID: 32611257
[TBL] [Abstract][Full Text] [Related]
16. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.
Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD
Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927
[TBL] [Abstract][Full Text] [Related]
17. Role of calcineurin and protein phosphatase-2A in the regulation of phosphatase inhibitor-1 in cardiac myocytes.
El-Armouche A; Bednorz A; Pamminger T; Ditz D; Didié M; Dobrev D; Eschenhagen T
Biochem Biophys Res Commun; 2006 Aug; 346(3):700-6. PubMed ID: 16774736
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the phosphatase PP2B by protein-protein interactions.
Nygren PJ; Scott JD
Biochem Soc Trans; 2016 Oct; 44(5):1313-1319. PubMed ID: 27911714
[TBL] [Abstract][Full Text] [Related]
19. Calcineurin regulation of cytoskeleton organization: a new paradigm to analyse the effects of calcineurin inhibitors on the kidney.
Descazeaud V; Mestre E; Marquet P; Essig M
J Cell Mol Med; 2012 Feb; 16(2):218-27. PubMed ID: 21801302
[TBL] [Abstract][Full Text] [Related]
20. NFAT transcription factors are critical survival factors that inhibit cardiomyocyte apoptosis during phenylephrine stimulation in vitro.
Pu WT; Ma Q; Izumo S
Circ Res; 2003 Apr; 92(7):725-31. PubMed ID: 12663489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]